[1]
|
Yamamoto, H., Watanabe, Y., Maehata, T., et al. (2014) An Updated Review of Gastric Cancer in the Next-Generation Sequencing Era: Insights from Bench to Bedside and Vice Versa. World Journal of Gastroenterology, 20, 3927-3937.
https://doi.org/10.3748/wjg.v20.i14.3927
|
[2]
|
Durães, C., Almeida, G.M., Seruca, R., et al. (2014) Biomarkers for Gastric Cancer: Prognostic, Predictive or Targets of Therapy? Virchows Arch, 464, 367-378. https://doi.org/10.1007/s00428-013-1533-y
|
[3]
|
Wang, J., Yu, J.C., Kang, W.M., et al. (2012) Treatment Strategy for Early Gastric Cancer. Surgical Oncology, 21, 119-123. https://doi.org/10.1016/j.suronc.2010.12.004
|
[4]
|
Hou, Y.C., Hu, Q., Huang, J., et al. (2017) Metformin Therapy and the Risk of Colorectal Adenoma in Patients with Type 2 Diabetes: A Meta-Analysis. Oncotarget, 8, 8843-8853. https://doi.org/10.18632/oncotarget.13633
|
[5]
|
Castilla-Guerra, L., Fernandez-Moreno, M.D., Leon-Jimenez, D., et al. (2018) Antidiabetic Drugs and Stroke Risk. Current Evidence. European Journal of Internal Medicine, 48, 1-5. https://doi.org/10.1016/j.ejim.2017.09.019
|
[6]
|
Zhou, G., Myers, R., Li, Y., et al. (2001) Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action. Journal of Clinical Investigation, 108, 1167-1174. https://doi.org/10.1172/JCI13505
|
[7]
|
Decensi, A., Puntoni, M., Goodwin, P., et al. (2010) Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis. Cancer Prevention Research, 3, 1451-1461.
https://doi.org/10.1158/1940-6207.CAPR-10-0157
|
[8]
|
Evans, J.M.M., Donnelly, L.A., Emslie-Smith, A.M., et al. (2005) Metformin and Reduced Risk of Cancer in Diabetic Patients. BMJ, 330, 1304-1305. https://doi.org/10.1136/bmj.38415.708634.F7
|
[9]
|
Wu, L., Zhu, J., Prokop, L.J., et al. (2015) Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies. Scientific Reports, 5, Article ID: 10147. https://doi.org/10.1038/srep10147
|
[10]
|
Thakkar, B., Aronis, K.N., Vamvini, M.T., et al. (2013) Metformin and Sulfonylureas in Relation to Cancer Risk in Type II Diabetes Patients: A Meta-Analysis Using Primary Data of Published Studies. Metabolism, 62, 922-934.
https://doi.org/10.1016/j.metabol.2013.01.014
|
[11]
|
Franciosi, M., Lucisano, G., Lapice, E., et al. (2013) Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review. PLoS ONE, 8, e71583. https://doi.org/10.1371/journal.pone.0071583
|
[12]
|
Soranna, D., Scotti, L., Zambon, A., et al. (2012) Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis. Oncologist, 17, 813-822. https://doi.org/10.1634/theoncologist.2011-0462
|
[13]
|
Noto, H., Goto, A., Tsujimoto, T., et al. (2012) Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-Analysis. PLoS ONE, 7, e33411. https://doi.org/10.1371/journal.pone.0033411
|
[14]
|
Kato, K., Gong, J., Iwama, H., et al. (2012) The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation in Vitro and in Vivo. Molecular Cancer Therapeutics, 11, 549-560.
https://doi.org/10.1158/1535-7163.MCT-11-0594
|
[15]
|
Valaee, S., Yaghoobi, M.M. and Shamsara, M. (2017) Metformin Inhibits Gastric Cancer Cells Metastatic Traits through Suppression of Epithelial-Mesenchymal Transition in a Glucose-Independent Manner. PLoS ONE, 12, e0174486. https://doi.org/10.1371/journal.pone.0174486
|
[16]
|
单争争, 王峰, 何炜, 等. 二甲双胍对IL-6诱导的胃癌SGC7901细胞上皮间质转化的影响[J]. 郑州大学学报(医学版), 2015, 50(3): 361-367.
|
[17]
|
Huang, D., He, X., Zou, J., et al. (2016) Negative Regulation of Bmi-1 by AMPK and Implication in Cancer Progression. Oncotarget, 7, 6188-6200. https://doi.org/10.18632/oncotarget.6748
|
[18]
|
Li, P., Tong, L., Song, Y., et al. (2019) Long Noncoding RNA H19 Participates in Metformin-Mediated Nhibition of Gastric Cancer Cell Invasion. Journal of Cellular Physiology, 234, 4515-4527. https://doi.org/10.1002/jcp.27269
|
[19]
|
Suzuki, H., Minegishi, Y., Nomoto, Y., et al. (2005) Down-Regulation of a Morphogen (Sonic Hedgehog) Gradient in the Gastric Epithelium of Helicobacter pylori-Infected Mongolian Gerbils. The Journal of Pathology, 206, 186-197.
https://doi.org/10.1002/path.1763
|
[20]
|
Berman, D.M., Karhadkar, S.S., Maitra, A., et al. (2003) Widespread Re-quirement for Hedgehog Ligand Stimulation in Growth of Digestive Tract Tumours. Nature, 425, 846-851. https://doi.org/10.1038/nature01972
|
[21]
|
Ma, X., Chen, K., Huang, S., et al. (2005) Frequent Activation of the Hedgehog Pathway in Advanced Gastric Adenocarcinomas. Carcinogenesis, 26, 1698-1705. https://doi.org/10.1093/carcin/bgi130
|
[22]
|
Song, Z., Yue, W., Wei, B., et al. (2011) Sonic Hedgehog Pathway Is Essential for Maintenance of Cancer Stem-Like Cells in Human Gastric Cancer. PLoS ONE, 6, e17687. https://doi.org/10.1371/journal.pone.0017687
|
[23]
|
Song, Z., Wei, B., Lu, C., et al. (2017) Metformin Suppresses the Expression of Sonic Hedgehog in Gastric Cancer Cells. Molecular Medicine Reports, 15, 1909-1915. https://doi.org/10.3892/mmr.2017.6205
|
[24]
|
Chen, G., Feng, W., Zhang, S., et al. (2015) Metformin Inhibits Gastric Cancer via the Inhibition of HIF1α/PKM2 Signaling. American Journal of Cancer Research, 5, 1423-1434.
|
[25]
|
Lu, C.C., Chiang, J.H., Tsai, F.J., et al. (2019) Metformin Triggers the Intrinsic Apoptotic Response in Human AGS Gastric Adenocarcinoma Cells by Activating AMPK and Suppressing mTOR/AKT Signaling. Interna-tional Journal of Oncology, 54, 1271-1281. https://doi.org/10.3892/ijo.2019.4704
|
[26]
|
吴诗文, 张自森, 刘谦, 等. 二甲双胍联合化疗药物对人胃癌AGS细胞的作用[J]. 郑州大学学报(医学版), 2017, 52(1): 37-41.
|
[27]
|
竹梦, 王建祥, 范渊, 等. 二甲双胍联合奥沙利铂抑制胃癌细胞SGC-7901的增殖和诱导凋亡[J]. 基因组学与应用生物学, 2017, 36(11): 4398-4405.
|
[28]
|
查璐琴, 韩本高, 张超杰. 二甲双胍通过Akt通路调控胃癌干细胞的增殖与凋亡[J]. 中国组织工程研究, 2019, 23(5): 657-662.
|
[29]
|
Courtois, S., Durán, R.V., Giraud, J., et al. (2017) Metformin Targets Gastric Cancer Stem Cells. European Journal of Cancer, 84, 193-201. https://doi.org/10.1016/j.ejca.2017.07.020
|
[30]
|
Sekino, N., Kano, M., Matsumoto, Y., et al. (2018) The Antitumor Effects of Metformin on Gastric Cancer in Vitro and on Peritoneal Metastasis. Anticancer Research, 38, 6263-6269. https://doi.org/10.21873/anticanres.12982
|
[31]
|
王一, 向勇平, 刘丹丹, 等. 二甲双胍对ALDH~+胃癌干细胞的抑制作用及其机制[J]. 解放军医学杂志, 2018, 43(1): 7-11.
|
[32]
|
Chen, G., Yu, C., Tang, Z., et al. (2019) Metformin Suppresses Gastric Cancer Progression through Calmodulin-Like Protein 3 Secreted from Tumor-Associated Fibroblasts. Oncology Reports, 41, 405-414.
https://doi.org/10.3892/or.2018.6783
|
[33]
|
Aroda, V.R., Edelstein, S.L., Goldberg, R.B., et al. (2016) Long-Term Metformin and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. The Journal of Clinical Endocrinology & Metabolism, 101, 1754-1761.
https://doi.org/10.1210/jc.2015-3754
|
[34]
|
Caspary, W.F., Zavada, I., Reimold, W., et al. (1977) Alteration of Bile Acid Metabolism and Vitamin-B12-Absorption Indiabetics on Biguanides. Diabetologia, 13, 187-193. https://doi.org/10.1007/BF01219698
|
[35]
|
Berchtold, P., Dahlqvist, A., Gustafson, A., et al. (1971) Effects of a Biguanide (Metformin) on Vitamin B 12 and Folic Acid Absorption and Intestinal Enzyme Activities. Scandinavian Journal of Gastroenterology, 6, 751-754.
https://doi.org/10.3109/00365527109179948
|
[36]
|
Bauman, W.A., Shaw, S., Jayatilleke, E., et al. (2000) Increased Intake of Calcium Reverses Vitamin B12 Malabsorption Induced by Metformin. Diabetes Care, 23, 1227-1231. https://doi.org/10.2337/diacare.23.9.1227
|
[37]
|
Bell, D.S. (2010) Metformin-Induced Vitamin B12 Deficiency Presenting as Aperipheral Neuropathy. The Southern Medical Journal, 103, 265-267. https://doi.org/10.1097/SMJ.0b013e3181ce0e4d
|